A randomized, controlled, multi-center study of thymoglobulin induction therapy with a calcineurin inhibitor sparing regimen in liver transplant patients.

Trial Profile

A randomized, controlled, multi-center study of thymoglobulin induction therapy with a calcineurin inhibitor sparing regimen in liver transplant patients.

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Aug 2013

At a glance

  • Drugs Antithymocyte globulin; Calcineurin inhibitors; Corticosteroids; Mycophenolate mofetil; Tacrolimus
  • Indications Liver transplant rejection
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Sep 2008 Planned end date is Jun 2008 according to the ClinicalTrials.gov record.
    • 28 Sep 2008 Status changed from active, no longer recruiting to completed according to the ClinicalTrials.gov record.
    • 12 Jan 2007 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top